SME Times is powered by   
Search News
Just in:   • Mishra launches Digital MSME scheme  • GST transition for SMEs  • GST, selling pressure spook investors, markets close lower  • AEPC joins hand with NSDL to assist exporters in GST compliances  • Apple, Cisco to help firms get cyber security insurance discounts 
Last updated: 23 Feb, 2017  
 Pharma


Lupin founder Gupta passes away in Mumbai
SME Times News Bureau | 27 Jun, 2017
Drug maker Lupin's founder and Chairman Desh Bandhu Gupta passed away here on Monday. He was 79.
  Read more....
Zydus Cadila gets USFDA nod for migraine drug
SME Times News Bureau | 20 Jun, 2017
Pharma major Zydus Cadila on Monday said it has received the final approval from the US Food and Drug Administration (FDA) to sell Eletriptan Hydrobromide tablets, used in the treatment of migraine.
  Read more....
Pfizer buys AstraZeneca's drug for Rs 75 cr
SME Times News Bureau | 01 Jun, 2017
American pharma major Pfizer's Indian arm on Wednesday announced that it had acquired the Neksium brand of the Swedish drug MNC AstraZeneca for Rs 75 crore.
  Read more....
Cipla's Q4 consolidated net loss at Rs 62 cr
SME Times News Bureau
Global pharmaceutical firm Cipla on Thursday reported a consolidated net loss of Rs 62 crore for the fourth quarter (Q4) of 2016-17.
  Read more....
Gland Pharma FDI proposal referred to Cabinet panel
SME Times News Bureau | 25 Apr, 2017
Foreign Investment Promotion Board (FIPB) has recommended the Rs 4,315-crore investment proposal of Gland Pharma Ltd to the Cabinet Committee on Economic Affairs (CCEA) for approval, an official statement said on Monday.
  Read more....
'Govt policy would succeed if generic drug quality improves'
SME Times News Bureau | 25 Apr, 2017
The Centre's steps to make doctors prescribe drugs by their generic names and not by their brand names may not have material impact without steps for improving the quality standards for drugs, investment banking firm Jefferies has said.
  Read more....
Muted fourth quarter expected for pharma sector: Jefferies
SME Times News Bureau | 07 Apr, 2017
The Indian pharmaceutical sector is expected to have a muted fourth quarter of last fiscal due to weak growth in US business, pricing while FY18 is likely to dominate the results, said investment banking firm Jefferies.
  Read more....
Lupin receives FDA approval for tablets, oral solution
SME Times News Bureau | 01 Mar, 2017
Pharma major Lupin Limited on Tuesday said that it has received final approval for its Oxycodone and Acetaminophen tablets and sodium, potassium and magnesium sulphate oral solution from the US Food and Drug Administration (FDA).
  Read more....
Pharma pricing regulator cuts stent prices by up to 85 pc
SME Times News Bureau | 15 Feb, 2017
In a major measure of relief to cardiac patients in India, the government on Tuesday fixed the ceiling price of coronary stents which are used to open up blocked arteries.
  Read more....
Trump's decision could hit Indian pharma exporters
SME Times News Bureau | 01 Feb, 2017
Foreshadowing "Buy American" moves that could affect the largest market for Indian pharmaceutical companies, US President Donald Trump told drug makers on Monday to bring back manufacturing to the United States.
  Read more....
 
  Customs Exchange Rates
Currency Import Export
US Dollar
65.15
63.50
UK Pound
83.40
80.60
Euro
73.45
70.95
Japanese Yen 59.75 57.70
As on 28 Jun, 2017
  Daily Poll
Should Govt tax farm income above certain level?
 Yes
 No
 Can't say
  Commented Stories
» Poor state of state finances(13)
» Starting an import export business: Basic guide for beginners(11)
» PMEGP to assist entrepreneurs financially: Dinesh Rai(2)
» Three years of Modi government(1)
» Air India unions warn govt of industrial unrest(1)
 
 
About Us  |   Advertise with Us  
  Useful Links  |   Terms and Conditions  |   Disclaimer  |   Contact Us  
Follow Us : Facebook Twitter